NCT07324278Recruiting
Hybrid Stroke Rehab With Mirror Priming
Hybrid Stroke Rehabilitation With Mirror Priming
Source: ClinicalTrials.gov · Last updated 25 Aug 2026
Brief summary (registry, in English)
This trial aims to examine the effects of enhanced mirror priming, overcoming the limitations of traditional mirror therapy, to achieve optimization and personalized intervention.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 81 (estimated)
- First submitted
- 23 Dec 2025
- Start date
- 2 Feb 2026
- Primary completion date
- 30 Sept 2030
- Lead sponsor
- I-Shou University
- Diseases
- Stroke
- NCT number
- NCT07324278
What you commit to
- Study type: Interventional
- Planned participants: 81
- From 2 Feb 2026 to the primary completion date, 30 Sept 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Received or planned botulinum toxin injections within 3 months prior to or during the trial
Other illness
- Serious medical problems or poor physical conditions that might be detrimental to study participation.
Who the study is looking for
- A first-ever unilateral stroke ≥3 months
- Age between 20 and 80 years
- Baseline Fugl-Meyer Assessment Upper Extremity (FMA-UE) score ≥ 10
- No severe spasticity in any joints of the affected arm
- Ability to follow the instructions
- No participation in other studies during the study period
- Willingness to provide informed written consent.
Age in the registry: 20 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| E-DA Hospital Coordinator of this site? Confirm its status | Kaohsiung City | Taiwan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.